Results 11 to 20 of about 209,031 (375)

Cardiac Resynchronization Therapy [PDF]

Cardiac Pacing and ICDs, 2020
Cardiac resynchronization therapy (CRT) is one of the most exciting recent advancements and has been revolutionary in the treatment of patients with congestive heart failure (CHF). CRT is a well-accepted therapy for the treatment of symptomatic systolic heart failure in defined patient subgroups.
Amanulla Khaji, Douglas Esberg
semanticscholar   +3 more sources

Comparison of methods for delivering cardiac resynchronization therapy: an acute electrical and haemodynamic within-patient comparison of left bundle branch area, His bundle, and biventricular pacing

Europace, 2023
Aims Left bundle branch area pacing (LBBAP) is a promising method for delivering cardiac resynchronization therapy (CRT), but its relative physiological effectiveness compared with His bundle pacing (HBP) is unknown.
N. Ali, A. Arnold, A. Miyazawa, D. Keene, J. Chow, Ian Little, N. Peters, P. Kanagaratnam, N. Qureshi, F. Ng, N. Linton, D. Lefroy, D. Francis, P. Lim, M. Tanner, A. Muthumala, M. Shun-shin, G. Cole, Z. Whinnett   +18 more
semanticscholar   +1 more source

The evolving state of cardiac resynchronization therapy and conduction system pacing: 25 years of research at EP Europace journal

Europace, 2023
Cardiac resynchronization therapy (CRT) was proposed in the 1990s as a new therapy for patients with heart failure and wide QRS with depressed left ventricular ejection fraction despite optimal medical treatment.
K. Ellenbogen, A. Auricchio, H. Burri, M. Gold, C. Leclercq, F. Leyva, C. Linde, M. Jastrzębski, F. Prinzen, K. Vernooy   +9 more
semanticscholar   +1 more source

Timing of cardiac resynchronization therapy implantation

Europace, 2023
Aims The optimum timing of cardiac resynchronization therapy (CRT) implantation is unknown. We explored long-term outcomes after CRT in relation to the time interval from a first heart failure hospitalization (HFH) to device implantation.
F. Leyva, A. Zegard, P. Patel, B. Stegemann, H. Marshall, P. Ludman, J. Walton, J. de Bono, G. Boriani, T. Qiu   +9 more
semanticscholar   +1 more source

Comparative effects of left bundle branch area pacing, His bundle pacing, biventricular pacing in patients requiring cardiac resynchronization therapy: A network meta‐analysis

Clinical Cardiology, 2022
The comparative effects of different types of cardiac resynchronization therapy (CRT) delivered by biventricular pacing (BVP), His bundle pacing (HBP), and left bundle branch area pacing (LBBAP) remain inconclusive.
Juan Hua, Chen-xi Wang, Q. Kong, Yichu Zhang, Qijun Wang, Ziyi Xiong, Jin-zhu Hu, Juxiang Li, Qi Chen, Kui Hong   +9 more
semanticscholar   +1 more source

Cardiac resynchronization therapy via left bundle branch pacing vs. optimized biventricular pacing with adaptive algorithm in heart failure with left bundle branch block: a prospective, multi-centre, observational study

Europace, 2021
Aims The purpose of our study was to evaluate the feasibility and efficacy of cardiac resynchronization therapy (CRT) via left bundle branch pacing (LBBP-CRT) compared with optimized biventricular pacing (BVP) with adaptive algorithm (BVP-aCRT) in heart ...
Xueying Chen, Y. Ye, Zhongkai Wang, Q. Jin, Zhaohui Qiu, Jingfeng Wang, Shengmei Qin, J. Bai, Wei Wang, Yixiu Liang, Hai-yan Chen, X. Sheng, F. Gao, Xianxian Zhao, G. Fu, K. Ellenbogen, Yangang Su, Junbo Ge   +17 more
semanticscholar   +1 more source

The relation between cardiac 123I-mIBG scintigraphy and functional response 1 year after CRT implantation [PDF]

, 2020
Cardiac resynchronization therapy (CRT) is a disease-modifying therapy in patients with chronic heart failure (CHF). Current guidelines ascribe CRT eligibility on three parameters only: left ventricular ejection fraction (LVEF), QRS duration, and New ...
de Groot, J R, De Vincentis, G, Frantellizzi, V, Gheysens, O, Nakajima, K, Poel, E, Verberne, H J, Verschure, D O   +7 more
core   +1 more source

Cardiac resynchronization therapy [PDF]

Europace, 2004
The first case report introducing the concept of cardiac resynchronisation therapy (CRT) was published less than 10 years ago, opening the way to the development of the first successful non-pharmacological treatment of congestive heart failure (CHF).
S, Cazeau, C, Alonso, G, Jauvert, A, Lazarus, P, Ritter   +4 more
openaire   +2 more sources

The response to cardiac resynchronization therapy in LMNA cardiomyopathy

European Journal of Heart Failure, 2022
Cardiac implantable electronic device (CIED) therapy is fundamental to the management of LMNA cardiomyopathy due to the high frequency of atrioventricular block and ventricular tachyarrhythmias.
K. Sidhu, A. I. Castrini, V. Parikh, N. Reza, A. Owens, Maxime Tremblay-Gravel, M. Wheeler, L. Mestroni, M. Taylor, S. Graw, M. Gigli, M. Merlo, A. Paldino, G. Sinagra, D. Judge, Hannia Ramos, Olurotimi O. Mesubi, E. Brown, S. Turnbull, S. Kumar, Darius Roy, U. Tedrow, L. Ngo, K. Haugaa, N. Lakdawala   +24 more
semanticscholar   +1 more source

Cardiac resynchronization therapy

Current Treatment Options in Cardiovascular Medicine, 2008
It is now well established that electrical and mechanical dyssynchrony are not clinically synonymous; however, at present no individual noninvasive method can reliably and consistently identify the criteria for mechanical dysfunction correctable through device therapy. The results of the PROSPECT (Predictors of Response to CRT) trial not only highlight
Daniel M, Couri, Sunil, Mankad
  +6 more sources